Moonwalk Biosciences founding team (L-R): CEO Alex Aravanis, COO Justin Valley, CBO Elaine Cheung, and president and CTO Arash Jamshidi. (Photo credit: Erin Beach)
Backed by CRISPR pioneer Feng Zhang, epigenetics biotech Moonwalk debuts with $57M
Moonwalk Biosciences has secured $57 million in seed and Series A funds to advance its epigenetics platform and preclinical pipeline in the latest endeavor by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.